Article Information
History
- June 12, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Wei Zhang1,2,
- Minjie Mou1,
- Wei Hu1,
- Mingkun Lu1,
- Hongning Zhang1,
- Yongchao Luo1,
- Hongquan Xu3,
- Hanyu Zhang1,
- Lin Tao3,
- Haibin Dai1,
- Jianqing Gao1,* and
- Feng Zhu1,2,*
- 1College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310058, China
- 2Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Hangzhou 330110, China
- 3Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China
- ↵* Address correspondence to: Prof. Feng ZHU (zhufeng{at}zju.edu.cn) and Prof. Jianqing GAO (gaojianqing{at}zju.edu.cn)
Posted June 12, 2023.
IE-MOIF: a novel multi-omics early integration framework for biomedical classification and biomarker discovery
